Dry Powder and Budesonide Inhalation Suspension Deposition Rates in Asthmatic Airway-Obstruction Regions
Open Access
- 18 November 2019
- journal article
- research article
- Published by Wiley in Journal of Drug Delivery
- Vol. 2019, 1-7
Abstract
Steroid inhalation is the standard bronchial asthma therapy and it includes powdered metered doses, dry powder, and nebulizer suspension. However, particle sizes vary widely. The research goal was to demonstrate that different budesonide administration forms and devices have various deposition rates in the airway obstruction region. Here, we compared relative inhalation therapy efficacies and identified therapies that delivered the highest drug doses to the airway obstruction region. Weibel’s anatomy data were used to identify the airway obstruction region in asthma. Based on European Standardization Committee data, we investigated the diameters of the drug particles being deposited there and evaluated the average particle size and distribution of the budesonide dosage forms and application devices. Drug dose depositions were measured by HPLC at each stage of a Cascade Impactor. Weibel’s anatomy data indicated that the 1st–4th bronchial generations comprised the airway obstruction region and corresponded to the tracheobronchial area. According to the European Standardization, particles 2–6 µm in diameter were readily deposited there. The proportions of particles in this size range were 33.0%, 32.0%, 59.0%, and 78.0% for Turbuhaler, Symbicort, mesh-type NE-U22 suspension, and jet-type NE-C28 suspension, respectively. We localized the airway obstruction regions of bronchial asthma and identified the optimal inhalation therapy particle size. An electric nebulizer was more efficacious for budesonide administration than dry powder delivery. The NE-C28 treatment deposited 2.36x more budesonide in the airway obstruction region than dry powder delivery systems.Keywords
This publication has 16 references indexed in Scilit:
- Assessment of Consistency of Fixed Airflow Obstruction Status during Budesonide/Formoterol Treatment and Its Effects on Treatment Outcomes in Patients with AsthmaThe Journal of Allergy and Clinical Immunology: In Practice, 2016
- Comparative Effectiveness of Budesonide-Formoterol Combination and Fluticasone-Salmeterol Combination for Asthma Management: A United States Retrospective Database AnalysisThe Journal of Allergy and Clinical Immunology: In Practice, 2014
- Treatment of the bronchial tree from beginning to end: targeting small airway inflammation in asthmaAllergy, 2012
- [Persistence rate for clinic visit in children with asthma after initiating controller therapy].2012
- Pathogenesis of Small Airways in AsthmaRespiration, 2012
- Lungenfunktionsdiagnostik der kleinen AtemwegePneumologie, 2012
- A Modified Marple-Type Cascade Impactor for Assessing Aerosol Particle Size Distributions in WorkplacesJournal of Occupational and Environmental Hygiene, 2007
- Particle size distributions of oil mists in workplace atmospheres and their exposure concentrations to workers in a fastener manufacturing industryJournal of Hazardous Materials, 2007
- Nebulized Budesonide Inhalation Suspension Compared With Cromolyn Sodium Nebulizer Solution for Asthma in Young Children: Results of a Randomized Outcomes TrialPediatrics, 2002
- Annexe A. Anatomy and morphology of the respiratory tractAnnals of the ICRP, 1994